Loading...
Printed on 7/19/2026
For informational purposes only. This is not medical advice.
The Mentzer Index (MCV ÷ RBC count) is a CBC-derived screening ratio to differentiate iron deficiency anemia from thalassemia trait in patients with microcytic anemia. Values <11.5 suggest thalassemia trait (many small, well-filled cells → high RBC count → low ratio); values >13 suggest iron deficiency anemia (few small, poorly-filled cells → low RBC count → high ratio); values 11.5–13 represent the overlap zone requiring iron studies and hemoglobin electrophoresis. Sensitivity is approximately 85–89% for each condition — Mentzer is a screening aid, not a diagnostic test. The physiological basis: thalassemia produces many under-hemoglobinized cells (high RBC count, low MCV), while iron deficiency produces fewer, more depleted cells (low RBC count, low MCV). Pair Mentzer screening with RDW: elevated RDW favors iron deficiency; normal RDW favors thalassemia trait.
Formula: Mentzer Index = MCV (fL) / RBC count (million/uL).
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
The Mentzer Index applies to patients with microcytic anemia — defined as hemoglobin below normal (Hb <12 g/dL in women, <13 g/dL in men) with MCV below 80 fL. The two most common causes of microcytic anemia are iron deficiency anemia (most common worldwide) and thalassemia trait (most common inherited red cell disorder, prevalent in Mediterranean, African, South/Southeast Asian, and Middle Eastern populations). From the CBC, identify two values: 1. **MCV (Mean Corpuscular Volume):** reported in femtoliters (fL). Normal adult range: 80–100 fL. In microcytic anemia, MCV is typically 60–79 fL; in severe iron deficiency, MCV may fall below 60 fL. 2. **RBC count:** reported in millions per microliter (× 10⁶/µL) or × 10¹²/L internationally. Normal adult range: 4.5–5.5 million/µL in men, 4.0–5.0 million/µL in women. Also note the **RDW (Red Cell Distribution Width)** — this is highly informative alongside the Mentzer Index. RDW reflects variation in red cell size. Elevated RDW (>14.5%) suggests iron deficiency (heterogeneous cells — a mix of normal and depleted cells as iron stores are depleted progressively). Normal RDW (<14.5%) with microcytosis suggests thalassemia trait (homogeneous small cells — all red cells are uniformly small because of the genetic alpha or beta chain deficit).
Perform the simple division: Mentzer Index = MCV (fL) ÷ RBC count (million/µL). Example 1 (thalassemia pattern): MCV = 68 fL, RBC count = 6.2 million/µL → Mentzer Index = 68 ÷ 6.2 = 10.97 (<11.5 → suggests thalassemia trait). Note the high-normal to elevated RBC count despite microcytosis — this is the thalassemia hallmark. The bone marrow compensates for the hemoglobin deficiency by producing more red cells, but each cell is small and under-hemoglobinized. Example 2 (iron deficiency pattern): MCV = 64 fL, RBC count = 3.8 million/µL → Mentzer Index = 64 ÷ 3.8 = 16.84 (>13 → suggests iron deficiency). Note the low RBC count with microcytosis — this reflects absolute iron deficiency impairing all red cell production. Iron-deficient red cells are small (low MCV) AND reduced in number (low RBC count). Example 3 (overlap zone): MCV = 70 fL, RBC count = 5.5 million/µL → Mentzer Index = 70 ÷ 5.5 = 12.73 (11.5–13 → overlap zone). This borderline result requires confirmatory testing to distinguish the two diagnoses. Interpretation thresholds: **<11.5** = thalassemia trait pattern (sensitivity ~85–89%). **11.5–13** = overlap zone (indeterminate — requires iron studies ± hemoglobin electrophoresis). **>13** = iron deficiency anemia pattern (sensitivity ~85–89%).
The Mentzer Index guides but does not replace confirmatory testing. Based on the result: **Mentzer <11.5 (thalassemia pattern):** Order iron studies to rule out concurrent iron deficiency (serum ferritin is the best single test — normal ferritin in a patient with Mentzer <11.5 strongly supports thalassemia trait). If ferritin is normal and the anemia is mild (Hb 10–12 g/dL, not requiring treatment), send hemoglobin electrophoresis (HPLC) to confirm thalassemia type: beta-thalassemia trait is diagnosed by elevated Hb A2 (>3.5%) ± elevated Hb F; alpha-thalassemia trait shows normal electrophoresis (alpha thal requires molecular testing). Avoid empiric iron supplementation in patients with thalassemia trait — iron therapy does not help and may cause iron overload with repeated use. **Mentzer 11.5–13 (overlap zone):** Order comprehensive iron studies: serum ferritin, serum iron, total iron-binding capacity (TIBC), transferrin saturation. If iron studies confirm iron deficiency (ferritin <20–30 ng/mL, low iron, high TIBC, low transferrin saturation), treat with iron supplementation and repeat CBC in 4–8 weeks. If iron studies are normal, proceed to hemoglobin electrophoresis to diagnose thalassemia trait. **Mentzer >13 (iron deficiency pattern):** Confirm with ferritin (most sensitive and specific for iron stores). Ferritin <12 ng/mL is virtually diagnostic of iron depletion; <30 ng/mL with concurrent inflammation suggests functional iron deficiency. Identify the source of iron deficiency (diet, malabsorption, blood loss — especially GI in adults). Treat with oral iron (ferrous sulfate 325 mg TID or ferrous gluconate/fumarate) and investigate the underlying cause. **Special consideration — combined iron deficiency + thalassemia:** The most diagnostically challenging scenario. A patient with beta-thalassemia trait who also develops iron deficiency may have a 'normalized' Mentzer Index (the low RBC count from iron deficiency partially cancels the high RBC count from thalassemia). This combination is common in women of reproductive age from thalassemia-prevalent regions. Clinical suspicion should guide comprehensive testing (iron studies + hemoglobin electrophoresis) regardless of the Mentzer Index result.
Primary care physicians and nurse practitioners
When a routine CBC reveals microcytic anemia in an asymptomatic patient, use the Mentzer Index as the first step to triage the most likely diagnosis before ordering expensive confirmatory tests. In a young woman from a Mediterranean or Southeast Asian background with mild anemia and no symptoms, a Mentzer Index <11.5 with normal RDW strongly suggests thalassemia trait — guiding thalassemia-specific confirmatory testing (hemoglobin electrophoresis) rather than empiric iron supplementation, which would be ineffective and potentially harmful with repeated use.
Obstetricians, midwives, and genetic counselors
Thalassemia trait is especially important to identify before pregnancy or in the first trimester. If both partners carry thalassemia trait (particularly beta-thalassemia), each pregnancy has a 25% chance of thalassemia major (Cooley's anemia) — a life-threatening condition requiring lifelong transfusion or bone marrow transplant. The Mentzer Index, combined with CBC findings, provides rapid initial screening to identify women who need urgent hemoglobin electrophoresis and partner testing. Carriers from high-prevalence regions (Mediterranean, Middle East, South/Southeast Asia, sub-Saharan Africa) should be screened before or early in pregnancy.
Internal medicine physicians and hematologists
Alpha and beta-thalassemia traits are highly prevalent in populations from malaria-endemic regions — beta-thalassemia prevalence reaches 10–15% in parts of Sardinia, Cyprus, Greece, Southeast Asia, and sub-Saharan Africa. When evaluating microcytic anemia in patients from these regions, the differential always includes thalassemia trait alongside iron deficiency. The Mentzer Index provides rapid initial stratification, with a low ratio (<11.5) prompting hemoglobin electrophoresis confirmation rather than unnecessary iron workup and supplementation.
Pediatricians and pediatric hematologists
Microcytic anemia is one of the most common pediatric hematologic findings. In toddlers and young children, iron deficiency from inadequate dietary intake (excessive cow's milk, iron-poor diet) is the most common cause. In children from thalassemia-prevalent ethnic backgrounds, thalassemia trait must be distinguished from dietary iron deficiency. The Mentzer Index provides rapid screening: a toddler with Mentzer >13 and low ferritin confirms iron deficiency requiring iron supplementation and dietary counseling. A child with Mentzer <11.5 and normal ferritin may have thalassemia trait — avoid iron supplementation and refer for hemoglobin electrophoresis.
Emergency medicine physicians and hospitalists
When an emergency patient presents with moderate anemia and CBC shows microcytosis, the Mentzer Index helps rapidly triage whether to start empiric iron therapy or order confirmatory testing first. In a patient with Mentzer >13 (iron deficiency pattern), empiric iron supplementation while awaiting confirmatory ferritin results is reasonable. In a patient with Mentzer <11.5 (thalassemia pattern), starting iron therapy would be inappropriate and potentially harmful — confirm diagnosis before treating. This distinction prevents the common error of empirically treating all microcytic anemias with iron.
The physiological basis of the Mentzer Index: thalassemia trait causes impaired hemoglobin chain synthesis, resulting in under-hemoglobinized red cells. The bone marrow compensates by increasing RBC production — the RBC count is often NORMAL or HIGH (4.5–6.5 million/µL) despite low hemoglobin and low MCV. This high RBC count relative to the low MCV gives a LOW Mentzer Index (e.g., MCV 68 ÷ RBC 6.2 = 10.97). Iron deficiency, conversely, impairs all erythropoiesis — both MCV drops AND RBC count drops. The depleted RBC count relative to the low MCV gives a HIGH Mentzer Index (MCV 64 ÷ RBC 3.8 = 16.8). Remember: thalassemia = 'many small cells' (low ratio); iron deficiency = 'few small cells' (high ratio).
Red Cell Distribution Width (RDW) measures the variation in red cell size (anisocytosis). In iron deficiency anemia, RBCs are produced progressively smaller as iron stores deplete, creating a heterogeneous population of normal-sized and small cells — resulting in elevated RDW (>14.5–15%). In thalassemia trait, all red cells are uniformly small (homogeneous microcytosis) because the genetic defect affects all erythroid precursors equally — RDW is typically NORMAL (<14.5%). The combination of low MCV + elevated RDW strongly favors iron deficiency; low MCV + normal RDW strongly favors thalassemia trait. This RDW distinction is more reliable than Mentzer Index in the 11.5–13 overlap zone. Check RDW on every CBC in microcytic anemia — it is reported automatically and provides free additional discriminatory information.
The Mentzer Index has reported sensitivity and specificity of approximately 85–89% for distinguishing thalassemia trait from iron deficiency anemia. This means approximately 11–15% of cases will be misclassified by Mentzer alone. Critically, a 'normal' Mentzer Index in a patient with microcytic anemia does NOT exclude thalassemia or iron deficiency — it simply suggests one is more likely than the other. Always confirm with: serum ferritin (for iron deficiency) and hemoglobin electrophoresis / HPLC (for thalassemia trait). The Mentzer Index is a triage tool to direct which confirmatory test to order first and to avoid empiric iron supplementation in patients with a thalassemia pattern.
Beta-thalassemia trait is diagnosed by hemoglobin electrophoresis showing elevated Hb A2 (>3.5%) with or without elevated Hb F. However, alpha-thalassemia trait (deletion of 1 or 2 of the 4 alpha-globin genes) often shows NORMAL hemoglobin electrophoresis in adults because the excess beta chains self-associate into Hb A without accumulating abnormal bands. Alpha-thalassemia 2 trait (one gene deletion, also called 'silent carrier') is nearly always diagnosed incidentally on CBC; alpha-thalassemia 1 trait (two gene deletions) shows microcytosis similar to beta-thalassemia trait but NORMAL electrophoresis. Diagnosis requires molecular testing (alpha-globin gene deletion analysis) or detection of Hb H inclusions (beta-chain tetramers) on brilliant cresyl blue stain. When a patient has Mentzer <11.5 but normal hemoglobin electrophoresis, strongly consider alpha-thalassemia trait — especially in Southeast Asian and African patients.
A patient with thalassemia trait can develop concurrent iron deficiency (from menstrual blood loss, GI bleeding, pregnancy). This combination creates a Mentzer Index 'towards the middle' — iron deficiency raises the ratio (from the reduced RBC count) while thalassemia lowers it (from the elevated RBC count), resulting in a value in the 11.5–13 overlap range. Additionally, hemoglobin electrophoresis in concurrent iron deficiency may show FALSELY NORMAL Hb A2 (iron deficiency suppresses Hb A2 synthesis) — this can mask an underlying beta-thalassemia trait. The appropriate workup: (1) Check ferritin — if low, treat iron deficiency first. (2) Repeat hemoglobin electrophoresis AFTER iron repletion (wait 3 months of iron therapy). (3) If Hb A2 then rises to >3.5% after iron repletion, confirm beta-thalassemia trait. Partner testing and genetic counseling if pregnancy is planned.
Always order serum ferritin alongside the Mentzer Index when evaluating microcytic anemia. Ferritin is the storage form of iron and is the most sensitive and specific single test for iron deficiency: ferritin <12 ng/mL is virtually diagnostic of depleted iron stores (near 100% specificity); ferritin <30 ng/mL in a patient with microcytic anemia is highly suggestive of iron deficiency. Caveat: ferritin is an acute-phase reactant — it is falsely elevated in inflammation, infection, liver disease, and malignancy. In patients with these conditions, a ferritin of 30–100 ng/mL with transferrin saturation <16% and elevated TIBC (functional iron deficiency of inflammation or anemia of chronic disease) may still represent iron-restricted erythropoiesis. Use the full iron panel (ferritin + serum iron + TIBC + transferrin saturation) for complete iron status assessment.
Thalassemia trait is particularly important to identify in pregnant women because of the genetic implications for the fetus. If both parents carry beta-thalassemia trait, each pregnancy has a 25% chance of thalassemia major (Cooley's anemia), which requires lifelong RBC transfusions every 2–3 weeks or allogeneic bone marrow transplantation for cure. Similarly, if both parents carry alpha-thalassemia 1 trait (two gene deletions), each pregnancy has a 25% chance of Hb Bart's hydrops fetalis — a fatal condition incompatible with extrauterine life. Identify pregnant women with Mentzer <11.5 or normal RDW microcytosis for urgent hemoglobin electrophoresis and partner testing. Prenatal diagnosis (chorionic villus sampling or amniocentesis) is available if both partners are carriers.
The Mentzer Index was designed to differentiate iron deficiency from thalassemia trait, but other conditions can cause microcytic anemia that may give misleading results: **Anemia of chronic disease (ACD):** Can cause microcytosis (usually mild), elevated ferritin (unless concurrent iron deficiency — 'mixed' ACD + IDA). Mentzer result is variable. **Sideroblastic anemia:** Ringed sideroblasts on bone marrow biopsy; dimorphic CBC (mixed micro- and normocytic cells); high RDW. **Lead poisoning:** Marked microcytosis, elevated free erythrocyte protoporphyrin, basophilic stippling on smear. **Vitamin B6 (pyridoxine) deficiency:** Rare cause of sideroblastic microcytic anemia. **HbC, HbE, HbS-beta thalassemia:** Other hemoglobin variants causing microcytosis; detected on electrophoresis. When Mentzer Index is high (>13) but ferritin is normal, consider these alternative diagnoses and proceed to hemoglobin electrophoresis.
Mentzer index was proposed by Mentzer et al. (Blood 1973) as a simple screening index from the CBC. Sensitivity and specificity for thalassemia trait vs iron deficiency reported as ~85% in subsequent validation studies. A meta-analysis by Demir et al. (J Pediatr Hematol Oncol 2010) found comparable performance across ethnic populations. Hemoglobin electrophoresis (HPLC) remains the gold standard for definitive thalassemia diagnosis.
Mentzer Index <11.5 suggests thalassemia trait pattern (many small cells, high RBC count, normal iron stores). Mentzer Index 11.5–13 is an overlap zone requiring comprehensive iron studies and hemoglobin electrophoresis. Mentzer Index >13 suggests iron deficiency anemia pattern (few small cells, low RBC count, depleted iron stores). Confirm all results with serum ferritin and/or hemoglobin electrophoresis. Sensitivity is approximately 85–89% — do not rely on Mentzer alone.
Use in patients with confirmed microcytic anemia (MCV <80 fL with Hb below normal) as an initial triage tool before targeted confirmatory testing. Most useful in outpatient primary care, prenatal screening, and pediatric anemia evaluation. Do NOT use in recently transfused patients (unreliable for 3–4 months post-transfusion).
Mentzer Index is not diagnostic and can be misleading in: mixed etiologies (concurrent iron deficiency + thalassemia trait), recently transfused patients, alpha-thalassemia trait (may give low index but normal hemoglobin electrophoresis), anemia of chronic disease, and sideroblastic anemia. Sensitivity ~85–89% means 11–15% misclassification rate. Always confirm with iron studies and/or hemoglobin electrophoresis.
For related assessments, see NLR Ratio, 4T Score (HIT) and DIC Score.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Calculate NLR from absolute neutrophil and lymphocyte counts as an inflammatory and prognostic marker.
OpenHematologyScore HIT pretest probability with the validated 4T tool. Score ≤3: >99% NPV — HIT unlikely. Score ≥4: stop heparin and switch anticoagulants. Free clinical calculator.
OpenHematologyEstimate overt disseminated intravascular coagulation probability using the ISTH scoring framework.
Open